Drug eruption and cutaneous metastasis in a patient with ALK-negative anaplastic large T-cell lymphoma after tislelizumab.

Su, Ting; Luan, Xingbao; Lu, Yan; Xu, Yang

Su, Ting; Luan, Xingbao; Lu, Yan; Xu, Yang.

Afiliación

Su T; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Luan X; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lu Y; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xu Y; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Australas J Dermatol ; 2024 Jun 19.

Article en En | MEDLINE | ID: mdl-38895816

Palabras clave

ALCL; CD30; ICIs; cutaneous metastasis; drug eruption

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Australas J Dermatol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google